Example: Heart Attack
Search clinical trials for: Maytansine
Total 107 results
-
NCT04189211Active, not recruitingConditions: HER2-Positive Solid Tumors
-
NCT04606914Not yet recruitingConditions: Ovarian Cancer; Fallopian Tube; Primary Peritoneal Cancer
-
NCT04296890RecruitingConditions: Epithelial Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer
-
NCT03832361RecruitingConditions: Endometrial Cancer
-
NCT03106077CompletedConditions: Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Estrogen Receptor Negative; Folate Receptor Alpha Positive; HER2/Neu Negative; Progesterone Receptor Negative; Prognostic Stage II Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Triple-Negative Breast Carcinoma
-
NCT03045393WithdrawnConditions: Breast Cancer Triple Negative
-
NCT03023722CompletedConditions: Pancreatic Cancer
-
NCT02839681TerminatedConditions: Lung Neoplasms
-
NCT02696642CompletedConditions: Neoplasms
-
NCT01638936CompletedConditions: Multiple Myeloma
-
NCT01609556CompletedConditions: Tumors
-
NCT01001442CompletedConditions: Multiple Myeloma
-
NCT01470456CompletedConditions: Diffuse Large B-Cell Lymphoma
-
NCT01440179TerminatedConditions: Acute Lymphocytic Leukaemia
-
NCT01472887CompletedConditions: Diffuse Large B-cell Lymphoma
-
NCT03926143Enrolling by invitationConditions: Cancer
-
NCT02420873CompletedConditions: Leukemia
-
NCT02254044TerminatedConditions: Carcinoma, Squamous Cell
-
NCT02254031TerminatedConditions: Breast Neoplasms
-
NCT02254018CompletedConditions: Head and Neck Neoplasms
-
NCT02254005CompletedConditions: Breast Neoplasms
-
NCT03836157WithdrawnConditions: Endometrial Cancer; Endometrial Adenocarcinoma; Endometrial Serous Adenocarcinoma; Endometrial Clear Cell Adenocarcinoma
-
NCT03552471RecruitingConditions: BRCA1 Gene Mutation; BRCA2 Gene Mutation; Folate Receptor Alpha Positive; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Uterine Corpus Carcinoma; Recurrent Uterine Serous Carcinoma; Recurrent Uterine Carcinosarcoma; Platinum Resistant Ovarian Cancer
-
NCT03126630RecruitingConditions: Pleural Malignant Mesothelioma
-
NCT02996825RecruitingConditions: Recurrent Breast Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Uterine Corpus Carcinoma; Triple-Negative Breast Carcinoma